The combination of the PARP inhibitor olaparib and the PD-1 inhibitor pembrolizumab showed initial antitumor activity with no new safety signals in a molecularly matched, tumor-agnostic trial, ...

Combining Lynparza (olaparib) and Keytruda (pembrolizumab) showed antitumor activity in multiple cancer types, particularly those with BRCA1/2 ...

Combining Lynparza (olaparib) and Keytruda (pembrolizumab) showed antitumor activity in multiple cancer types, particularly those with BRCA1/2 mutations. In this combination trial patients were ...

Miguel continues to deal with the long-term effects of his cancers and treatments. He was also recently diagnosed with ...

it is BRCA mutation-negative and homologous recombination deficiency (HRD)-positive, or it is BRCA mutation-negative, and HRD status is negative or unknown, and bevacizumab is not a treatment option ...

Prime Minister Narendra Modi has given instructions to the Gujarat government to ensure that there is "no deficiency" in former finance minister P Chidambaram’s treatment. The senior Congress leader ...

During meiosis, at least one crossover is selectively generated per pair of homologous chromosomes through homologous recombination to ensure their faithful segregation. The molecular mechanisms ...

Nutritionist Deepshikha Jain shared the 8 signs of vitamin D deficiency, including disturbed sleep, dry skin, and more. She also suggested taking supplements. Vitamin D deficiency is a common ...

Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea ...

Vitamin B12 deficiency affects more than a billion people worldwide. Currently, the primary dietary sources of this essential micronutrient (recommended at 2.4 µg/day) are meat and dairy products — ...